Chien‐Feng Chen

1.1k total citations
7 papers, 195 citations indexed

About

Chien‐Feng Chen is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Chien‐Feng Chen has authored 7 papers receiving a total of 195 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 2 papers in Genetics and 2 papers in Immunology. Recurrent topics in Chien‐Feng Chen's work include Platelet Disorders and Treatments (5 papers), Blood groups and transfusion (4 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Chien‐Feng Chen is often cited by papers focused on Platelet Disorders and Treatments (5 papers), Blood groups and transfusion (4 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Chien‐Feng Chen collaborates with scholars based in United States, Netherlands and United Kingdom. Chien‐Feng Chen's co-authors include Janet L. Nichol, Martin R. Schipperus, Marie Thérèse Caulier, Adrian C. Newland, François Lefrère, M. C. Kappers‐Klunne, Jaap Jan Zwaginga, P. Duncombe, Ethan B. Russo and Kerri A. Schoedel and has published in prestigious journals such as Blood, British Journal of Haematology and Journal of Dental Sciences.

In The Last Decade

Chien‐Feng Chen

7 papers receiving 187 citations

Peers

Countries citing papers authored by Chien‐Feng Chen

Since Specialization

Citations

This map shows the geographic impact of Chien‐Feng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chien‐Feng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chien‐Feng Chen more than expected).

Fields of papers citing papers by Chien‐Feng Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chien‐Feng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chien‐Feng Chen. The network helps show where Chien‐Feng Chen may publish in the future.

Co-authorship network of co-authors of Chien‐Feng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Chien‐Feng Chen. A scholar is included among the top collaborators of Chien‐Feng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chien‐Feng Chen. Chien‐Feng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Comprehensive orthognathic correction of post-traumatic Le-Fort II deformity 2017 ·Journal of Dental Sciences ·(unknown), Chien‐Feng Chen, Yu‐Hsuan Li, Yuan‐Wu Chen	2
2	A Multiple‐Dose, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group QT/QTc Study to Evaluate the Electrophysiologic Effects of THC/CBD Spray 2013 ·Clinical Pharmacology in Drug Development ·Edward M. Sellers, Kerri A. Schoedel, (unknown), Myroslava K. Romach, Ethan B. Russo, Colin Stott, Stephen Wright, Linda R. White, P. Duncombe, Chien‐Feng Chen	29
3	An open‐label, unit dose‐finding study of AMG 531, a novel thrombopoiesis‐stimulating peptibody, in patients with immune thrombocytopenic purpura 2006 ·British Journal of Haematology ·Adrian C. Newland, Marie Thérèse Caulier, M. C. Kappers‐Klunne, Martin R. Schipperus, François Lefrère, Jaap Jan Zwaginga, (unknown), Chien‐Feng Chen, Janet L. Nichol	115
4	Safety Profile of AMG 531 in Healthy Volunteers and in Thrombocytopenic Patients with Immune Thromobocytopenic Purpura. 2005 ·Blood ·Daniel E. Stepan, (unknown), Reggie Kelly, (unknown), Chien‐Feng Chen, Janet L. Nichol	6
5	Long-Term Dosing of AMG 531 Is Effective and Well Tolerated in Thrombocytopenic Patients with Immune Thrombocytopenic Purpura. 2005 ·Blood ·James B. Bussel, David J. Kuter, James N. George, Louis M. Aledort, Alan Lichtin, Roger M. Lyons, Jorge J. Nieva, Jeffrey S. Wasser, (unknown), M. C. Kappers‐Klunne, François Lefrère, Martin R. Schipperus, Reggie Kelly, (unknown), Chien‐Feng Chen, Janet L. Nichol	18
6	An Open-Label, Unit Dose-Finding Study Evaluating the Safety and Platelet Response of a Novel Thrombopoietic Protein (AMG531) in Thrombocytopenic Adult Patients (Pts) with Immune Thrombocytopenic Purpura (ITP). 2004 ·Blood ·Adrian C. Newland, Marie Thérèse Caulier, Martin R. Schipperus, (unknown), Bruno Varet, Karen E. Watkins, Chien‐Feng Chen, Janet L. Nichol	15
7	A Phase 2 Placebo Controlled Study Evaluating the Platelet Response and Safety of Weekly Dosing with a Novel Thrombopoietic Protein (AMG531) in Thrombocytopenic Adult Patients (pts) with Immune Thrombocytopenic Purpura (ITP). 2004 ·Blood ·David J. Kuter, James B. Bussel, Louis M. Aledort, James N. George, Roger M. Lyons, George T. Conklin, Alan Lichtin, Jorge J. Nieva, Reggie Kelly, Chien‐Feng Chen, Janet L. Nichol	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact